James M. Thorburn - Dec 8, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Financial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for James M. Thorburn
Stock symbol
TWST
Transactions as of
Dec 8, 2021
Transactions value $
-$544,443
Form type
4
Date filed
12/10/2021, 03:57 PM
Previous filing
Nov 23, 2021
Next filing
Dec 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $81.1K +7K +16.02% $11.59 50.7K Dec 8, 2021 Direct
transaction TWST Common Stock Sale -$16.7K -200 -0.39% $83.34 50.5K Dec 8, 2021 Direct F1, F2
transaction TWST Common Stock Sale -$22.9K -267 -0.53% $85.72 50.2K Dec 8, 2021 Direct F1, F3
transaction TWST Common Stock Sale -$52.2K -600 -1.19% $87.08 49.6K Dec 8, 2021 Direct F1, F4
transaction TWST Common Stock Sale -$73.4K -831 -1.67% $88.37 48.8K Dec 8, 2021 Direct F1, F5
transaction TWST Common Stock Sale -$215K -2.4K -4.92% $89.73 46.4K Dec 8, 2021 Direct F1, F6
transaction TWST Common Stock Sale -$200K -2.21K -4.77% $90.51 44.2K Dec 8, 2021 Direct F1, F7
transaction TWST Common Stock Sale -$44.9K -491 -1.11% $91.35 43.7K Dec 8, 2021 Direct F1, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -7K -19.27% $0.00 29.3K Dec 8, 2021 Common Stock 7K $11.59 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 16, 2020.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $83.28 to $83.40 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $85.28 to $86.13 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 Represents the weighted average sales price per share. The shares sold at prices ranging from $86.84 to $87.67 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5 Represents the weighted average sales price per share. The shares sold at prices ranging from $87.90 to $88.80 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F6 Represents the weighted average sales price per share. The shares sold at prices ranging from $89.13 to $90.12 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F7 Represents the weighted average sales price per share. The shares sold at prices ranging from $90.19 to $90.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F8 Represents the weighted average sales price per share. The shares sold at prices ranging from $91.20 to $91.46 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F9 The option is immediately exercisable. 25% of the shares subject to the option vested on April 23, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.